Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells

Journal of Lipid Research

Volumn 54, Issue 3, 2013, Pages 692-710

  Kouzel, Ivan U ^a   Pohlentz, Gottfried ^a   Storck, Wiebke ^a   Radamm, Lena ^a   Hoffmann, Petra ^a   Bielaszewska, Martina ^a   Bauwens, Andreas ^a   Cichon, Christoph ^a   Schmidt, M Alexander ^a   Mormann, Michael ^a   Karch, Helge ^a   Müthing, Johannes ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

1,3 GalNAcT; 1,4 GalT; EHEC STEC; Galactosyltransferases; Gb3Cer; Gb4Cer; Glycolipids; Lyso phosphatidylcholine

Indexed keywords

CHOLESTEROL; DETERGENT; GLYCOSYLTRANSFERASE; PHOSPHOLIPID; RECEPTOR; SHIGA TOXIN GLYCOSPHINGOLIPID RECEPTOR; SHIGA TOXIN RECEPTOR; SPHINGOMYELIN; UNCLASSIFIED DRUG; VEROTOXIN 2;

ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL DAMAGE; CELL MEMBRANE; CELL STRAIN; CELL STRAIN HL 60; CELL STRAIN THP 1; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; HUMAN; HUMAN CELL; IMMUNODETECTION; LEUKEMIA CELL LINE; LIPID RAFT; LYMPHOID CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAJI CELL; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

BLOTTING, WESTERN; CELL LINE; CELL PROLIFERATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GALACTOSYLTRANSFERASES; GLOBOSIDES; GLYCOSPHINGOLIPIDS; HL-60 CELLS; HUMANS; LYMPHOCYTES; MEMBRANE MICRODOMAINS; MYELOID CELLS; N-ACETYLGALACTOSAMINYLTRANSFERASES; REAL-TIME POLYMERASE CHAIN REACTION; SHIGA TOXIN; TRIHEXOSYLCERAMIDES;

EID: 84874086213     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M031781     Document Type: Article

References (117)

1. Pike, L. J. 2009. The challenge of lipid rafts. J. Lipid Res. 50 : S323-S328.
2. Lingwood, D., and K. Simons. 2010. Lipid rafts as a membraneorganizing principle. Science. 327 : 46-50.
3. Simons, K., and M. J. Gerl. 2010. Revitalizing membrane rafts: new tools and insights. Nat. Rev. Mol. Cell Biol. 11 : 688-699.
4. Sonnino, S., A. Prinetti, L. Mauri, V. Chigorno, and G. Tettamanti. 2006. Dynamic and structural properties of sphingolipids as driving forces for the formation of membrane domains. Chem. Rev. 106 : 2111-2125.
5. Prinetti, A., N. Loberto, V. Chigorno, and S. Sonnino. 2009. Glycosphingolipid behaviour in complex membranes. Biochim. Biophys. Acta. 1788 : 184-193.
6. Westerlund, B., and J. P. Slotte. 2009. How the molecular features of glycosphingolipids affect domain formation in fl uid membranes. Biochim. Biophys. Acta. 1788 : 194-201.
7. Gupta, G., and A. Surolia. 2010. Glycosphingolipids in microdomain formation and their spatial organization. FEBS Lett. 584 : 1634-1641.
8. Brown, D. A., and J. K. Rose. 1992. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell. 68 : 533-544.
9. London, E., and D. A. Brown. 2000. Insolubility of lipids in Triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim. Biophys. Acta. 1508 : 182-195.
10. Lingwood, D., and K. Simons. 2007. Detergent resistance as a tool in membrane research. Nat. Protoc. 2 : 2159-2165.
11. Levery, S. B. 2005. Glycosphingolipid structural analysis and glycosphingolipidomics. Methods Enzymol. 405 : 300-369.
12. Merrill, A. H., Jr. 2011. Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem. Rev. 111 : 6387-6422.
13. Meisen, I., M. Mormann, and J. Müthing. 2011. Thin-layer chromatography, overlay technique and mass spectrometry: a versatile triad advancing glycosphingolipidomics. Biochim. Biophys. Acta. 1811 : 875-896.
14. Thudichum, J. L. W. 1884. A treatise on the chemical constitution of the brain. Baillière, Tindall, and Cox, London, UK.
15. Merrill, A. H., Jr., E. M. Schmelz, D. L. Dillehay, S. Spiegel, J. A. Shayman, J. J. Schroeder, R. T. Riley, K. A. Voss, and E. Wang. 1997. Sphingolipids: the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol. Appl. Pharmacol. 142 : 208-225.
16. Pruett, S. T., A. Bushnev, K. Hagedorn, M. Adiga, C. A. Haynes, M. C. Sullards, D. C. Liotta, and A. H. Merrill, Jr. 2008. Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols. J. Lipid Res. 49 : 1621-1639.
17. Müthing, J., and U. Distler. 2010. Advances on the compositional analysis of glycosphingolipids combining thin-layer chromatography with mass spectrometry. Mass Spectrom. Rev. 29 : 425-479.
18. Lahiri, S., and A. H. Futerman. 2007. The metabolism and function of sphingolipids and glycosphingolipids. Cell. Mol. Life Sci. 64 : 2270-2284.
19. Wennekes, T., R. J. B. H. N. van den Berg, R. G. Boot, G. A. van der Marel, H. S. Overkleeft, and J. M. F. G. Aerts. 2009. . Glycosphingolipids- nature, function, and pharmacological modulation. Angew. Chem. Int. Ed. Engl 48 : 8848-8869.
20. García-Vallejo, J. J., S. I. Gringhuis, W. van Dijk, and I. van Die. 2006. Gene expression analysis of glycosylation-related genes by real-time PCR. Methods Mol. Biol. 347: 187-209.
21. Fantini, J., M. Maresca, D. Hammache, N. Yahi, and O. Delézay. 2000. Glycosphingolipid (GSL) microdomain as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: activation of signal transduction pathways and perturbations of intestinal absorption and secretion. Glycoconj. J. 17 : 173-179.
22. Hakomori, S. I. 2000. Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain. Glycoconj. J. 17 : 143-151.
23. Regina Todeschini, A., and S. I. Hakomori. 2008. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim. Biophys. Acta. 1780 : 421-433.
24. Yu, R. K., Y. Nakatani, and M. Yanagisawa. 2009. The role of glycosphingolipid metabolism in the developing brain. J. Lipid Res. 50 : S440-S445.
25. Hakomori, S. I. 2010. Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and mortality. FEBS Lett. 584 : 1901-1906.
26. Kasahara, K., and Y. Sanai. 2000. Functional roles of glycosphingolipids in signal transduction via lipid rafts. Glycoconj. J. 17 : 153-162.
27. Sorice, M., A. Longo, T. Garofalo, V. Mattei, R. Misasi, and A. Pavan. 2004. Role of GM3-enriched microdomains in signal transduction regulation in T lymphocytes. Glycoconj. J. 20 : 63-70.
28. Lingwood, C. A. 2011. Glycosphingolipid functions. Cold Spring Harb. Perspect. Biol. 3 : pii: a004788.
29. Miller-Podraza, H., L. Johansson, P. Johansson, T. Larsson, M. Matrosovich, and K-A. Karlsson. 2000. A strain of human infl uenza A virus binds to extended but not short gangliosides as assayed by thin-layer chromatography overlay. Glycobiology. 10 : 975-982.
30. Meisen, I., T. Dzudzek, C. Ehrhardt, S. Ludwig, M. Mormann, R. Rosenbrück, R. Lümen, B. Kniep, H. Karch, and J. Müthing. 2012. The human H3N2 infl uenza viruses A/Victoria/3/75 and A/Hiroshima/52/2005 preferentially bind to 2-3-sialylated monosialogangliosides with fucosylated poly-N-acetyllactosaminyl chains. Glycobiology. 22 : 1055-1076.
31. Karlsson, K-A. 1989. Animal glycosphingolipids as membrane attachment sites for bacteria. Annu. Rev. Biochem. 58 : 309-350.
32. Miller-Podraza, H., P. Johansson, J. Ångström, T. Larsson, M. Longard, and K-A. Karlsson. 2004. Studies on gangliosides with affi nity for Helicobacter pylori : binding to natural and chemically modifi ed structures. Glycobiology. 14 : 205-217.
33. Smith, D. C., J. M. Lord, L. M. Roberts, and L. Johannes. 2004. Glycosphingolipids as toxin receptors. Semin. Cell Dev. Biol. 15 : 397-408.
34. Lingwood, C. A., B. Binnington, A. Manis, and D. R. Branch. 2010. Globotriaosyl ceramide receptor function-Where membrane structure and pathology intersect. FEBS Lett. 584 : 1879-1886.
35. Obrig, T. G. 2010. Escherichia coli Shiga toxin mechanisms of action in renal disease. Toxins. 2 : 2769-2794.
36. Endo, Y., K. Tsurugi, T. Yutsudo, Y. Takeda, T. Ogasawara, and K. Igarashi. 1988. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 171 : 45-50.
37. Brigotti, M., R. Alfi eri, P. Sestili, M. Bonelli, P. G. Petronini, A. Guidarelli, L. Barbieri, F. Stirpe, and S. Sperti. 2002. Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells. FASEB J. 16 : 365-372.
38. Brigotti, M., D. Carnicelli, E. Ravanelli, A. G. Vara, C. Martinelli, R. A. Alfi eri, P. G. Petronini, and P. Sestili. 2007. Molecular damage and induction of proinfl ammatory cytokines in human endothelial cells exposed to Shiga toxin 1, Shiga toxin 2, and-sarcin. Infect. Immun. 75 : 2201-2207.
39. Lingwood, C. A. 1996. Role of verotoxin receptors in pathogenesis. Trends Microbiol. 4 : 147-153.
40. Distler, U., J. Souady, M. Hülsewig, I. Drmi?-Hofman, J. Haier, A. W. Friedrich, H. Karch, N. Senninger, K. Dreisewerd, S. Berkenkamp, et al. 2009. Shiga toxin receptor Gb3Cer/CD77: tumor association and promising therapeutic target in pancreas and colon cancer. PLoS ONE. 4 : e6813.
41. Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shiga-toxinproducing Escherichia coli and haemolytic uraemic syndrome. Lancet. 365 : 1073-1086.
42. Bielaszewska, M., A. Mellmann, W. Zhang, R. Köck, A. Fruth, A. Bauwens, G. Peters, and H. Karch. 2011. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect. Dis. 11 : 671-676.
43. Mellmann, A., D. Harmsen, C. A. Cummings, E. B. Zentz, S. R. Leopold, A. Rico, K. Prior, R. Szczepanowski, Y. Ji, W. Zhang, et al. 2011. Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PLoS ONE. 6 : e22751.
44. Betz, J., M. Bielaszewska, A. Thies, H. U. Humpf, K. Dreisewerd, H. Karch, K. S. Kim, A. W. Friedrich, and J. Müthing. 2011. Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains. J. Lipid Res. 52 : 618-634.
45. Betz, J., A. Bauwens, L. Kunsmann, M. Bielaszewska, M. Mormann, H. U. Humpf, H. Karch, A. W. Friedrich, and J. Müthing. 2012. Uncommon membrane distribution of Shiga toxin glycosphingolipid receptors in toxin-sensitive human glomerular microvascular endothelial cells. Biol. Chem. 393 : 133-147.
46. Bauwens, A., J. Betz, I. Meisen, B. Kemper, H. Karch, and J. Müthing. 2012. Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature. Cell. Mol. Life Sci. In press.
47. Te Loo, D. M. W. M., L. A. H. Monnens, T. J. A. M. van der Velden, M. A. Vermeer, F. Preyers, P. N. M. Demacker, L. P. W. J. van den Heuvel, and V. W. M. van Hinsbergh. 2000. Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood. 95 : 3396-3402.
48. Flagler, M. J., J. E. Strasser, C. L. Chalk, and A. A. Weiss. 2007. Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and infl uence neutrophil apoptosis. Infect. Immun. 75 : 760-765.
49. Griener, T. P., G. L. Mulvey, P. Marcato, and G. D. Armstrong. 2007. Differential binding of Shiga toxin 2 to human and murine neutrophils. J. Med. Microbiol. 56 : 1423-1430.
50. Brigotti, M., D. Carnicelli, E. Ravanelli, S. Barbieri, F. Ricci, A. Bontadini, A. E. Tozzi, G. Scavia, A. Caprioli, and P. L. Tazzari. 2008. Interactions between Shiga toxins and human polymorphonuclear leukocytes. J. Leukoc. Biol. 84 : 1019-1027.
51. Arfi lli, V., D. Carnicelli, L. Rocchi, F. Ricci, P. Pagliaro, P. L. Tazzari, and M. Brigotti. 2010. Shiga toxin 1 and ricin A chain bind to human polymorphonuclear leucocytes through a common receptor. Biochem. J. 432 : 173-180.
52. Brigotti, M., D. Carnicelli, V. Arfi lli, L. Rocchi, F. Ricci, P. Pagliaro, P. L. Tazzari, A. G. Vara, M. Amelia, F. Manoli, et al. 2011. Change in conformation with reduction of-helix content causes loss of neutrophil binding activity in fully cytotoxic Shiga toxin 1. J. Biol. Chem. 286 : 34514-34521.
53. Brigotti, M., P. L. Tazzari, E. Ravanelli, D. Carnicelli, S. Barbieri, L. Rocchi, V. Arfi lli, G. Scavia, F. Ricci, A. Bontadini, et al. 2010. Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration. J. Leukoc. Biol. 88 : 201-210.
54. Müthing, J., S. Duvar, D. Heitmann, F. G. Hanisch, U. Neumann, G. Lochnit, R. Geyer, and J. Peter-Katalini?. 1999. Isolation and structural characterization of glycosphingolipids of in vitro propagated human umbilical vein endothelial cells. Glycobiology. 9 : 459-468.
55. Geelen, J. M., T. J. van der Velden, L. P. van den Heuvel, and L. A. Monnens. 2007. Interactions of Shiga-like toxin with human peripheral blood monocytes. Pediatr. Nephrol. 22 : 1181-1187.
56. Brigotti, M. 2012. The interactions of human neutrophils with Shiga toxins and related plant toxins: danger or safety? Toxins. 4 : 157-190.
57. Weiss, A., R. L. Wiskocil, and J. D. Stobo. 1984. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production refl ects events occurring at a pre-translational level. J. Immunol. 133 : 123-128.
58. Pulvertaft, J. V. 1964. Cytology of Burkitt's tumour (African lymphoma). Lancet. 1 : 238-240.
59. Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, and T. Konno. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer. 26 : 171-176.
60. Gallagher, R., S. Collins, J. Trujillo, K. McCredie, M. Ahearn, S. Tsai, R. Metzgar, G. Aulakh, R. Ting, F. Ruscetti, et al. 1979. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood. 54 : 713-733.
61. Hoffmann, P., M. Hülsewig, S. Duvar, H. Ziehr, M. Mormann, J. Peter-Katalini?, A. W. Friedrich, H. Karch, and J. Müthing. 2010. On the structural diversity of Shiga toxin glycosphingolipid receptors in lymphoid and myeloid cells determined by nanoelectrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 24 : 2295-2304.
62. Bauwens, A., M. Bielaszewska, B. Kemper, P. Langehanenberg, G. von Bally, R. Reichelt, D. Mulac, H-U. Humpf, A. W. Friedrich, K. S. Kim, et al. 2011. Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells. Thromb. Haemost. 105 : 515-528.
63. Schweppe, C. H., M. Bielaszewska, G. Pohlentz, A. W. Friedrich, H. Büntemeyer, M. A. Schmidt, K. S. Kim, J. Peter-Katalini?, H. Karch, and J. Müthing. 2008. Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity. Glycoconj. J. 25 : 291-304.
64. Saito, T., and S. I. Hakomori. 1971. Quantitative isolation of total glycosphingolipids from animal cells. J. Lipid Res. 12 : 257-259.
65. Li, Y., S. Teneberg, P. Thapa, A. Bendelac, S. B. Levery, and D. Zhou. 2008. Sensitive detection of isoglobo and globo series tetraglycosylceramides in human thymus by ion trap mass spectrometry. Glycobiology. 18 : 158-165.
66. Li, Y., D. Zhou, C. Xia, P. G. Wang, and S. B. Levery. 2008. Sensitive quantitation of isoglobotriaosylceramide in the presence of isobaric components using electrospray ionization-ion trap mass spectrometry. Glycobiology. 18 : 166-176.
67. Meisen, I., A. W. Friedrich, H. Karch, U. Witting, J. Peter-Katalini?, and J. Müthing. 2005. Application of combined highperformance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-fl ight tandem mass spectrometry to the structural characterization of high-and low-affi nity binding ligands of Shiga toxin 1. Rapid Commun. Mass Spectrom. 19 : 3659-3665.
68. Souady, J., J. Soltwisch, K. Dreisewerd, J. Haier, J. Peter-Katalini?, and J. Müthing. 2009. Structural profi ling of individual glycosphingolipids in a single thin-layer chromatogram by multiple sequential immunodetection matched with direct IR-MALDI-o-TOF mass spectrometry. Anal. Chem. 81 : 9481-9492.
69. Chester, M. A. 1998. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of glycolipids. Recommendations 1997. Glycoconj. J. 16 : 1-6.
70. Müthing, J., C. H. Schweppe, H. Karch, and A. W. Friedrich. 2009. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb. Haemost. 101 : 252-264.
71. Distler, U., M. Hülsewig, J. Souady, K. Dreisewerd, J. Haier, N. Senninger, A. W. Friedrich, H. Karch, F. Hillenkamp, S. Berkenkamp, et al. 2008. Matching IR-MALDI-o-TOF mass spectrometry with the TLC overlay binding assay and its clinical application for tracing tumor-associated glycosphingolipids in hepatocellular and pancreatic cancer. Anal. Chem. 80 : 1835-1846.
72. Schweppe, C. H., P. Hoffmann, J-R. Nofer, G. Pohlentz, M. Mormann, H. Karch, A. W. Friedrich, and J. Müthing. 2010. Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors. J. Lipid Res. 51 : 2282-2294.
73. Storck, W., I. Meisen, K. Gianmoena, I. Pläger, I. U. Kouzel, M. Bielaszewska, J. Haier, M. Mormann, H. U. Humpf, H. Karch, et al. 2012. Shiga toxin glycosphingolipid receptor expression and toxin susceptibility of human pancreatic ductal adenocarcinomas of differing origin and differentiation. Biol. Chem. 393 : 785-799.
74. Müthing, J. 1998. TLC in structure and recognition studies of glycosphingolipids. In Methods in molecular biology. E. F. Hounsell, editor. Humana Press Inc., Totawa, NJ. 183-195.
75. Dittmer, J. C., and R. L. Lester. 1964. A simple, specifi c spray for the detection of phospholipids on thin-layer chromatograms. J. Lipid Res. 1 5 : 126-127.
76. Müthing, J., and M. Radloff. 1998. Nanogram detection of phospholipids on thin-layer chromatograms. Anal. Biochem. 257 : 67-70.
77. Goswami, S. K., and C. F. Frey. 1970. Manganous chloride spray reagent for cholesterol and bile acids on thin-layer chromatograms. J. Chromatogr. 53 : 389-390.
78. Souady, J., M. Hülsewig, U. Distler, J. Haier, A. Denz, C. Pilarsky, N. Senninger, K. Dreisewerd, J. Peter-Katalini?, and J. Müthing. 2011. Differences in CD75s-and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues. Glycobiology. 21 : 584-594.
79. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 : 248-254.
80. Zor, T., and Z. Selinger. 1996. Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Anal. Biochem. 236 : 302-308.
81. Meisen, I., J. Peter-Katalini?, and J. Müthing. 2003. Discrimination of neolacto-series gangliosides with 2-3-and 2-6-linked N-acetylneuraminic acid by nanoelectrospray ionization low-energy collision-induced dissociation tandem quadrupole TOF MS. Anal. Chem. 75 : 5719-5725.
82. Meisen, I., J. Peter-Katalini?-, and J. Müthing. 2004. Direct analysis of silica gel extracts from immunostained glycosphingolipids by nanoelectrospray ionization quadrupole time-of-fl ight mass spectrometry. Anal. Chem. 76 : 2248-2255.
83. Müthing, J., I. Meisen, W. Zhang, M. Bielaszewska, M. Mormann, R. Bauerfeind, M. A. Schmidt, A. W. Friedrich, and H. Karch. 2012. Promiscuous Shiga toxin 2e and its intimate relationship to Forssman. Glycobiology. 22 : 849-862.
84. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, 2010. Available at: http://www.R-project.org.
85. Hennet, T. 2002. The galactosyltransferase family. Cell. Mol. Life Sci. 59 : 1081-1095.
86. Chatterjee, S., A. Kolmakova, and M. Rajesh. 2008. Regulation of lactosylceramide synthase (glucosylceramide 1 ? 4 galactosyltransferase): implication as a drug target. Curr. Drug Targets. 9 : 272-281.
87. Macher, B. A., and J. C. Klock. 1980. Isolation and chemical characterization of neutral glycosphingolipids of human neutrophils. J. Biol. Chem. 255 : 2092-2096.
88. Kiguchi, K., C. B. Henning-Chubb, and E. Huberman. 1990. Glycosphingolipid patterns of peripheral blood lymphocytes, monocytes, and granulocytes are cell specifi c. J. Biochem. 107 : 8-14.
89. Nojiri, H., F. Takaku, T. Tetsuka, K. Motoyoshi, Y. Miura, and M. Saito. 1984. Characteristic expression of glycosphingolipid profi les in the bipotential cell differentiation of human promyelocytic leukemia cell line HL-60. Blood. 64 : 534-541.
90. Buehler, J., E. Qwan, M. W. DeGregorio, and B. A. Macher. 1985. Biosynthesis of glycosphingolipids by human myeloid leukemia cells. Biochemistry. 24 : 6978-6984.
91. Kniep, B., D. A. Monner, U. Schwuléra, and P. F. Mühlradt. 1985. Glycosphingolipids of the globo-series are associated with the monocytic lineage of human myeloid cells. Eur. J. Biochem. 149 : 187-191.
92. Stults, C. L. M., R. D. Larsen, and B. A. Macher. 1995. 1,4Galactosyltransferase activity and Gb 3 Cer expression in human leukaemia/lymphoma cell lines. Glycoconj. J. 12 : 680-689.
93. Kim, M., B. Binnington, D. Sakac, K. R. Fernandes, S. P. Shi, C. A. Lingwood, and D. R. Branch. 2011. Comparison of detection methods for cell surface globotriaosylceramide. J. Immunol. Methods. 371 : 48-60.
94. Harrison, A. L., M. L. Olsson, R. B. Jones, S. Ramkumar, D. Sakac, B. Binnington, S. Henry, C. A. Lingwood, and D. R. Branch. 2010. A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms. Glycoconj. J. 27 : 515-524.
95. Kolmakova, A., and S. Chatterjee. 2005. Platelet derived growth factor recruits lactosylceramide to induce cell proliferation in UDP Gal:GlcCer: 1 ? 4galactosyltransferase (GalT-V) mutant Chinese hamster ovary cells. Glycoconj. J. 22 : 401-407.
96. Kumagai, T., T. Sato, S. Natsuka, Y. Kobayashi, D. Zhou, T. Shinkai, S. Hayakawa, and K. Furukawa. 2010. Involvement of murine-1,4-galactosyltransferase V in lactosylceramide biosynthesis. Glycoconj. J. 27 : 685-695.
97. Lee, S. Y., R. P. Cherla, I. Caliskan, and V. L. Tesh. 2005. Shiga toxin 1 induces apoptosis in the human myelogenous leukemia cell line THP-1 by a caspase-8-dependent, tumor necrosis factor receptor-independent mechanism. Infect. Immun. 73 : 5115-5126.
98. Lee, S. Y., M. S. Lee, R. P. Cherla, and V. L. Tesh. 2008. Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells. Cell. Microbiol. 10 : 770-780.
99. Ramkumar, S., D. Sakac, B. Binnington, D. R. Branch, and C. A. Lingwood. 2009. Induction of HIV-1 resistance: cell susceptibility to infection is an inverse function of globotriaosyl ceramide levels. Glycobiology. 19 : 76-82.
100. Ramegowda, B., and V. L. Tesh. 1996. Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. Infect. Immun. 64 : 1173-1180.
101. Mahfoud, R., A. Manis, B. Binnington, C. Ackerley, and C. A. Lingwood. 2010. A major fraction of glycosphingolipids in model and cellular cholesterol-containing membranes is undetectable by their binding proteins. J. Biol. Chem. 285 : 36049-36059.
102. Lingwood, D., B. Binnington, T. Róg, I. Vattulainen, M. Grzybek, Ü. Coskun, C. A. Lingwood, and K. Simons. 2011. Cholesterol modulates glycolipid conformation and receptor activity. Nat. Chem. Biol. 7 : 260-262.
103. Saito, M., M. Mylvaganum, P. Tam, A. Novak, B. Binnington, and C. A. Lingwood. 2012. Structure-dependent pseudoreceptor intracellular traffi c of adamantyl globotriaosyl ceramide mimics. J. Biol. Chem. 287 : 16073-16087.
104. Kovbasnjuk, O., M. Edidin, and M. Donowitz. 2001. Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells. J. Cell Sci. 114 : 4025-4031.
105. Falguières, T., F. Mallard, C. Baron, D. Hanau, C. Lingwood, B. Gould, J. Salamero, and L. Johannes. 2001. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol. Biol. Cell. 12 : 2453-2468.
106. Falguières, T., W. Römer, M. Amessou, C. Afonso, C. Wolf, J-C. Tabet, C. Lamaze, and L. Johannes. 2006. Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells. FEBS J. 273 : 5205-5218.
107. Lencer, W. I., and D. Saslowsky. 2005. Raft traffi cking of AB 5 subunit bacterial toxins. Biochim. Biophys. Acta. 1746 : 314-321.
108. Smith, D. C., D. J. Sillence, T. Falguières, R. M. Jarvis, L. Johannes, J. M. Lord, F. M. Platt, and L. M. Roberts. 2006. The associa tion of Shiga-like toxin with detergent-resistant membranes is modulatedby glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect. Mol. Biol. Cell. 17 : 1375-1387.
109. Hanashima, T., M. Miyake, K. Yahiro, Y. Iwamaru, A. Ando, N. Morinaga, and M. Noda. 2008. Effect of Gb3 in lipid rafts in resistance to Shiga-like toxin of mutant Vero cells. Microb. Pathog. 45 : 124-133.
110. Tam, P., R. Mahfoud, A. Nutikka, A. A. Khine, B. Binnington, P. Paroutis, and C. Lingwood. 2008. Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies. J. Cell. Physiol. 216 : 750-763.
111. Raa, H., S. Grimmer, D. Schwudke, J. Bergan, S. Wälchli, T. Skotland, A. Shevchenko, and K. Sandvig. 2009. Glycosphingolipid requirements for endosome-to-Golgi transport of Shiga toxin. Traffi c. 10 : 868-882.
112. Sandvig, K., Ø. Garred, K. Prydz, J. V. Kozlov, S. H. Hansen, and B. van Deurs. 1992. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature. 358 : 510-512.
113. Sandvig, K., M. L. Torgersen, N. Engedal, T. Skotland, and T-G. Iversen. 2010. Protein toxins from plants and bacteria: Probes for intracellular transport and tools in medicine. FEBS Lett. 584 : 2626-2634.
114. Sandvig, K., J. Bergan, A. B. Dyve, T. Skotland, and M. L. Torgersen. 2010. Endocytosis and retrograde transport of Shiga toxin. Toxicon. 56 : 1181-1185.
115. Van der Luit, A. H., M. Budde, M. Verheij, and W. J. van Blitterswijk. 2003. Different modes of internalization of apoptotic alkyl-lysophospholipid and cell-rescuing lysophosphatidylcholine. Biochem. J. 374 : 747-753.
116. Varki, A. 2007. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature. 446 : 1023-1029.
117. Raman, R., M. Venkataraman, S. Ramakrishnan, W. Lang, S. Raguram, and R. Sasisekharan. 2006. Advancing glycomics: implementation strategies at the consortium for functional glycomics. Glycobiology. 16 : 82R-90R.